Haematology Division, ICMR - Regional Medical Research Centre, North East Region, Dibrugarh 786010, Assam (Department of Health Research, Ministry of Health & Family Welfare, Government of India).
Public Health Nutr. 2021 Dec;24(17):5589-5597. doi: 10.1017/S1368980021003670. Epub 2021 Aug 25.
Despite operational guidelines, anecdotal evidence suggests that newborn vitamin K1 prophylaxis is not practiced routinely in India. This study determined the coverage of vitamin K1 prophylaxis among newborns in the country.
Nationwide cross-sectional data on live births and newborns receiving vitamin K1 during the 2019-2020 reporting period were abstracted from the Health Management Information System (HMIS). The coverage estimates of newborn vitamin K1 prophylaxis were derived nationally and also for individual states and union territories (UT). Additionally, coverage heterogeneities were investigated using classifiers, viz. geography, socio-demographic index (SDI), special developmental categories and institutional birth rate (IBR).
India.
20 208 804 newborns documented with HMIS.
Vitamin K1 was administered to overall 62·36 % newborns (95 % CI: 62·34 to 62·38 %). The Central zone (49·0 %), low SDI states (54·39 %), Empowered Action Group states (53·32 %) and states with low IBR (44·69 %) had the lowest coverage amongst their respective groupings. Across the individual states and UT, the coverage ranged widely from 22·18 % (in Tripura) to 99·38 % (in Puducherry), exhibiting considerable variability (coefficient of variation: 33·74 %) and inequality (Gini coefficient: 0·17). While the coverage in eight states/UT (i.e. Arunachal Pradesh, Manipur, Nagaland, Tripura, Uttar Pradesh, Uttarakhand, Telangana and Andaman & Nicobar Islands) was below 50 %; only five states/UT (i.e. Chandigarh, Gujarat, Goa, Puducherry and Tamil Nadu) achieved above 90 % coverage.
Vitamin K1 prophylaxis was not practiced in more than one-third newborns in India. It calls for identifying the barriers, addressing the gaps and implementing newborn vitamin K1 prophylaxis more effectively throughout the country.
尽管有操作指南,但传闻证据表明,印度并未常规实施新生儿维生素 K1 预防措施。本研究旨在确定该国新生儿中维生素 K1 预防措施的覆盖率。
从健康管理信息系统(HMIS)中提取了 2019-2020 报告期内活产儿和接受维生素 K1 的新生儿的全国性横断面数据。全国范围内以及各个邦和联邦属地(UT)的新生儿维生素 K1 预防措施覆盖率的估计值都是通过分类器(即地理位置、社会人口指数(SDI)、特殊发育类别和机构出生率(IBR))计算得出的。
印度。
20208804 名记录在 HMIS 中的新生儿。
维生素 K1 已在总体 62.36%的新生儿中使用(95%CI:62.34-62.38%)。中央邦(49.0%)、SDI 较低的邦(54.39%)、赋权行动小组邦(53.32%)和 IBR 较低的邦(44.69%)在各自的分组中覆盖率最低。在各个邦和 UT 中,覆盖率差异很大,从 22.18%(特里普拉邦)到 99.38%(本地治里邦),差异很大(变异系数:33.74%)且不平等(基尼系数:0.17)。虽然有 8 个邦/UT(即阿鲁纳恰尔邦、曼尼普尔邦、那加兰邦、特里普拉邦、北方邦、北阿坎德邦、特伦甘纳邦和安达曼和尼科巴群岛)的覆盖率低于 50%;但只有 5 个邦/UT(即昌迪加尔邦、古吉拉特邦、果阿邦、本地治里邦和泰米尔纳德邦)的覆盖率超过 90%。
印度超过三分之一的新生儿未接受维生素 K1 预防措施。这需要确定障碍,解决差距,并在全国范围内更有效地实施新生儿维生素 K1 预防措施。